# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-019132
Filing Date
2023-04-19
Accepted
2023-04-19 16:06:37
Documents
3
Period of Report
2023-05-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20007569x1_def14a.htm | DEF 14A | 583175
2 |  | ny20007569x1-pc_1.jpg | GRAPHIC | 677438
3 |  | ny20007569x1-pc_2.jpg | GRAPHIC | 528355
| Complete submission text file | 0001140361-23-019132.txt |  | 2244116

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41455 | Film No.: 23830103
SIC: 2834 Pharmaceutical Preparations